Chemical Business Newsbase articles from February 2011

Chemical Business Newsbase archives from February 2011

Notice concerning the integration of dental materials businesses.
February 28, 2011... Kuraray Co Ltd and Noritake Co Ltd announced on 28 Jan 2011 a basic agreement regarding the integration of the dental materials businesses of their respective wholly owned subsidiaries Kuraray Medical Inc and Noritake Dental Supply Co Ltd. In...

Sinopec Shanghai Petrochemical report for 3Q 2010.
February 28, 2011... Sinopec Shanghai Petrochemical Co Ltd's operating income rose to RMB Yuan 55,179,683,000 in the nine months ended 31 Sep 2010 from RMB Yuan 34,264,070,000 in the nine months ended 31 Sep 2009. Operating profit rose to RMB Yuan 2,270,830,000 from...

Celanese announces price increases.
February 28, 2011... On 28 Feb 2011, Celanese Corp announced that it will increase list and off-list selling prices for the following products, in the amounts indicated, effective 1 Mar 2011, or as contracts allow. These price increases are in addition to all...

DSM completes acquisition of Martek; adding new nutrition growth platform.
February 28, 2011... On 28 Feb 2011, DSM NV announced that it has successfully completed the acquisition of Martek Biosciences Corp. The acquisition, announced on 21 Dec 2010, is the first major acquisition by DSM after its successful transformation into a Life...

Forest Laboratories Inc and Gedeon Richter plc announce results from a phase II study of cariprazine as adjunctive therapy in major depressive disorder.
February 28, 2011... On 28 Feb 2011, Forest Laboratories Inc and Gedeon Richter plc announced preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent cariprazine as adjunctive therapy in major depressive...

LANXESS to increase prices for its Baypren (CR) products.
February 28, 2011... The Technical Rubber Products (TRP) business unit of specialty chemicals group LANXESS announces a price increase for its Baypren branded Chloroprene business - depending on region - for up to EUR 300/tonne (or $ 400/tonne). Reason being the...

Mitsui Chemicals announces transfer of head office operations for high performance elastomer (TAFMER) to Singapore.
February 28, 2011... On 28 Feb 2011, Mitsui Chemicals Inc announced that it has decided to transfer head office functions for its high performance elastomer TAFMER, one of the company's five world-leading businesses, to Singapore as part of its new Mid-Term Business...

Green energy spend hits GBP 150 bn in 2010.
February 28, 2011... Global investment in green energy soared by 30% to a record $243 bn (GBP 151 bn) in 2010, according to figures released on 28 Feb 2011. Yet growth is geographically patchy and some key markets are still struggling in the aftermath of the credit...

Russia fertilizers producers struggling for raw material.
February 28, 2011... OAO Apatit (Fosagro subsidiary) and OAO Kovdorskii GOK (both from Russia) are the only apatite suppliers to the domestic market. GOK has capacity for 2.7 M tones/y of apatite and 16% of the market. Apatit has capacity for 7.5 M tonnes/y....

Trius announces positive results from Phase I lung study of torezolid phosphate.
February 28, 2011... Trius Therapeutics Inc (Trius) announced results from its Phase I clinical trial to evaluate the ability of torezolid phosphate to penetrate into the lung for potential use to treat lung infections. In this study a 200 mg dose of torezolid...

The 4Q 2010 profit falls, may sell LipoSonix unit: Medicis Pharmaceutical.
February 28, 2011... Medicis' investors have not been warm to the idea of the dermatological company expanding into the fat-busting technology, which is undergoing clinical trials and is years away from FDA approval. During first week of Mar 2011, plans call for...

Innate Pharma receives a milestone payment for IPH 2201, a monoclonal antibody licensed to Novo Nordisk A/S.
February 28, 2011... Innate Pharma announced that a European trial application has been filed by Novo Nordisk A/S for IPH 2201 (NN8765). This triggered the payment to Innate Pharma of a significant undisclosed milestone. IPH2201 is a humanized antibody generated in...

ASTAR scientists discover cause of rare skin cancer that heals itself.
February 28, 2011... Institute of Medical Biology (IMB) scientists under the Agency of Science, Technology and Research (ASTAR) in Singapore are part of an international team of researchers who became the first in the world to discover the gene behind a rare skin...

HP speeds drug discovery research with Inkjet Technology.
February 28, 2011... HP announced an innovative drug research application for its inkjet technology that enables pharmaceutical companies to more efficiently develop better drugs through vastly more precise dispensing of dosages. HP high-performance inkjet...

For the treatment of acute heart failure, the highest proportion of surveyed cardiologists identify furosemide as the most efficacious agent, when compared to other available therapies.
February 28, 2011... Decision Resources finds that the highest proportion of surveyed cardiologists identify furosemide (Sanofi-Aventis's Lasix, generics) as the most efficacious agent for the treatment of acute heart failure when compared to other available...

PerkinElmer introduces Signature Precision Panel.
February 28, 2011... PerkinElmer Inc's Signature Genomics Laboratories has launched its new Signature Precision Panel Prenatal diagnostic test for rapid testing of 15 common and severe chromosomal disorders. The Signature Precision Panel Prenatal test is designed...

Derma Sciences receives FDA clearance for Medihoney Gel.
February 28, 2011... Derma Sciences Inc announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for the company's patent-pending Medihoney Gel Wound and Burn Dressing. This latest Medihoney line extension is dispensed from a tube and is...

FDA grants Priority Review for Istodax sNDA for treatment of progressive or relapsed PTCL.
February 28, 2011... Celgene Corp announced that the US Food and Drug Administration (FDA) has granted Priority Review classification to its Supplemental New Drug Application (sNDA) regarding Istodax (romidepsin) for injection for the treatment of peripheral T-cell...

Epigenomics and Qiagen sign collaboration agreement in colorectal cancer blood testing.
February 28, 2011... Epigenomics AG and Qiagen have entered into an option agreement allowing Qiagen to develop and, should Qiagen exercise the option, commercialize a colorectal cancer blood test based on Epigenomics' proprietary biomarker mSEPT9 and certain DNA...

Novavax licenses recombinant VLP influenza vaccine to LG Life Sciences for South Korea and other countries.
February 28, 2011... Novavax Inc announced an agreement to licence its proprietary, recombinant virus-like-particle (VLP) vaccine technology to LG Life Sciences Ltd (LGLS). Under the agreement, LGLS receives an exclusive licence to manufacture, develop and...

AFFiRiS announces an extension of its existing Alzheimer's disease vaccine development collaboration with GlaxoSmithKline triggering a EUR 3.5 M payment to AFFiRiS.
February 28, 2011... AFFiRiS AG announced significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer's disease. While the lead vaccine candidate AD02 is currently in...

Bacterin International announces major orthopaedic hospital group to begin use of OsteoSponge SC.
February 28, 2011... Bacterin International Holdings Inc (Bacterin) a developer of revolutionary bone graft material, announced that its recently launched OsteoSponge SC, a highly effective subchondral bone void filler, is being successfully used by a high volume...

FDA approves INTUNIV (guanfacine) extended-release tablets for use as adjunctive therapy to stimulants for the treatment of ADHD in children and adolescents.
February 28, 2011... Shire plc, the global speciality biopharmaceutical company, announced that the US Food and Drug Administration (FDA) approved the use of once-daily INTUNIV (guanfacine) Extended-Release Tablets as adjunctive therapy to stimulants for the...

LDK Solar closes offering of RMB Yuan 1.2 bn US dollar settled senior notes due 2014.
February 28, 2011... LDK Solar Co Ltd has announced the closing of US dollar-settled 10% senior notes due 2014 in the aggregate principal amount of RMB Yuan 1.2 bn being offered and sold outside the US pursuant to Regulation S under the US Securities Act of 1933, as...

Peripheral neuropathic pain patients in Sweden set to benefit from first-of-a-kind treatment which provides lasting pain relief.
February 28, 2011... Patients in Sweden living with peripheral neuropathic pain are set to gain access to a new treatment option which can provide pain relief for up to three months following a single 30-minute or 60-minute application. The new treatment patch uses...

S BIO's novel dual mTOR/PI3 kinase inhibitor SB2343 demonstrates excellent PK/PD properties leading to significant anti-tumour efficacy in xenograft models.
February 28, 2011... S BIO Pte Ltd announced that its novel dual mTOR/PI3 Kinase inhibitor SB2343 demonstrated excellent pharmacokinetic/pharmacodynamic (PK/PD) properties leading to significant anti-tumour efficacy in rapamycin-sensitive and resistant xenograft...

PDL BioPharma announces regular quarterly dividend policy.
February 28, 2011... PDL BioPharma Inc (PDL) announced that its board of directors has adopted a regular dividend policy for 2011 and beyond and declared that the four quarterly dividends to be paid to its stockholders in 2011 will be $0.15/share of common stock....

Tide and Gain debut compacted powder laundry detergent at Target.
February 28, 2011... The new Tide and Gain compacted powder laundry detergents are now available at Target stores across the US. The new detergents are compacted by 33%, while offering the same number of loads in a smaller box. The compacted powder laundry...

BioSolar's breakthrough BioBacksheet receives official UL material certification.
February 28, 2011... BioSolar Inc developer of a breakthrough technology to produce bio-based materials from renewable plant sources that reduce the cost of photovoltaic (PV) solar modules, reported that its innovative BioBacksheet product has received full...

Pfizer announces updated, interactive development pipeline.
February 28, 2011... Pfizer Inc provided an update to its development pipeline. The updated pipeline includes an overview of the company's research and a list of compounds in development with targeted indication, phase of development and, for late-stage programmes,...

Affymetrix launches next-generation microRNA solution.
February 28, 2011... Affymetrix Inc on 28 Feb 2011 launched the GeneChip miRNA 2.0 Array. This enhanced version of its best-in-class microRNA (miRNA) interrogation solution will support the research community's pursuit of personalised medicine by accelerating the...

Praxair announces price increases.
February 28, 2011... Praxair Inc and its divisions and subsidiaries are notifying bulk and packaged industrial gas customers in the US and Canada of increases in prices effective 15 Mar 2011, or as contracts permit, as follows: Up to 15% for nitrogen, oxygen, argon,...

California gasoline consumption rose 2.6%, diesel increased 4.9%.
February 28, 2011... The Chairman of the California State Board of Equalization released California gasoline and diesel consumption figures for Nov 2010. California gasoline consumption increased 2.6% in Nov 2010 and diesel fuel consumption increased 4.9% compared...

Cytec completes sale of Building Block Chemicals business.
February 28, 2011... Cytec Industries Inc has completed the previously announced sale of its Building Block Chemicals business to an affiliate of HIG Capital LLC for approximately $180 M which includes a 6 year Note for $15 M. The total consideration is subject to...

GET G-OIL Motor Oil at Walmart.
February 28, 2011... Green Earth Technologies Inc (Green Earth) announced the distribution of their G-OIL 5W-30 Bio-based Full Synthetic Motor Oil in over 2,100 Walmart stores throughout the USA. G-OIL is the world's first and only American Petroleum Institute's...

Sangamo BioSciences announces presentation of positive clinical data from novel ZFN therapeutic approach for the treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections.(Conference news)
February 28, 2011... Sangamo BioSciences Inc (Sangamo) has announced the presentation of positive preliminary clinical data from its Phase I trial (SB-728-902). The trial is being conducted in immunologic non-responders, HIV-infected subjects who are currently on...

Santaris Pharma A/S obtains exclusive licence from Mass General Hospital for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders.
February 28, 2011... Santaris Pharma A/S has obtained an exclusive licence from Massachusetts General Hospital (MGH) for intellectual property related to the regulation of miR-33 for the treatment of cardiovascular disorders. Santaris Pharma A/S will utilize its...

Keyuan Petrochemicals Inc announces dividend payment schedule.
February 28, 2011... Keyuan Petrochemicals Inc (Keyuan) announced its payment schedule for its previously announced $0.36/share dividend for 2011. The first quarterly dividend of $0.09/share will be paid to shareholders of record as of 1 Mar 2011, with the...

EPAR summary for the public: Melosus (meloxicam).
February 28, 2011... This document is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the...

EPAR summary for the public: Activyl (indoxacarb).
February 28, 2011... This document is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the...

Take your foot off: chemicals producers are facing increasing pressure on product carbon footprints.
February 28, 2011... New government policies and continuous upgrading of codes of practice for suppliers by retail chains and brand owners are prompting speciality chemical producers to closely look at their products' PCFs (product carbon footprints), defined as the...

Building for the new: Clariant announced plans for a new 'Innovation Centre.'.
February 28, 2011... Swiss speciality chemicals major Clariant unveiled in Dec 2010 its plan to build a new 'Innovation Centre' at the Frankfurt-Hochst Industrial Park. The new facility will cover a total area of 23,000 sq m, including 10,500 sq m of laboratory...

Simply the pest: biopesticides were prominent at the first CropWorld show in London.
February 28, 2011... Biopesticides, which are plant protection products containing agents of biological origin, was a prominent theme at the CropWorld 2010 show that was held in London in early Nov 2010. AgraQuest, a major segment player, currently markets five...

Also in the news this month: AkzoNobel/Eldorado supply deal.
February 28, 2011... AkzoNobel has inked a 15-year deal for its unit Eka Chemicals to supply paper chemicals to Eldorado Celulose e Papel. In Jun 2010, Eldorado started building a new pulp mill in Tres Lagoas City, Brazil. The mill will have three pulp lines, with...

Also in the news this month: BASF restructures paper dyes business.
February 28, 2011... BASF has finished the revamp of its paper dyes business at a global level. Part of the restructuring was the closure of the basazol dyes plant in Ludwigshafen. The facility's 42 employees will be reassigned by the company.

Also in the news this month: Lanxess to expand synthetic menthol production.
February 28, 2011... Lanxess will ramp up synthetic menthol production at its facility in Krefeld-Uerdingen, Germany to cope with strong global demand from the aromas and pharmaceuticals sectors. The expansion is covered by the EUR 40 M investment by the firm's...

Also in the news this month: Lanxess to relocate some of its Indian facilities.
February 28, 2011... Lanxess will transfer some of its Indian plants from Madurai, Tamil Nadu to a newly opened facility in Jhagadia, Gujarat by end-2011. The firm will also install newer technologies as part of efforts to upgrade the relocated units. The move will...

Also in the news this month: AFC's new second semi-works facility.
February 28, 2011... Ampac Fine Chemicals' (AFC) second semi-works unit at its facility in Rancho Cordova, CA, USA became 100% operational during Jan 2011. The new plant was set up to support further growth in the firm's development pipeline. It is equipped to run...

Also in the news this month: Italian firm to move beyond its focus on generic APIs.
February 28, 2011... Dipharma Francis, an Italian firm focused on generic API production, aims to also build up its custom synthesis business. The firm has developed expertise in specialized chemistries, including hydrogenation, nitration and enzymes.

Also in the news this month: Novasep and InstrAction expand alliance.
February 28, 2011... Novasep and the German chromatographic stationary phase specialist InstrAction have broadened their partnership, which was originally announced in Jul 2010, to cover purification of taxanes. Taxanes have primary use in anti-cancer compounds....

Also in the news this month: GalChimia-Alfama partnership.
February 28, 2011... Portuguese pharmaceuticals company Alfama has agreed to work with Spanish synthetic chemistry services firm GalChimia to develop a candidate drug for treating post-operative ileus, a condition which causes a delay in patients' recovery of...

Also in the news this month: HallStar acquires BioChemica.
February 28, 2011... BioChemica International, a supplier of plant-derived exotic butters and oils, has been acquired by Chicago-based chemical firm HallStar. BioChemica will maintain its facility in Melbourne, FL, USA and continue to use its brand. All its...

Indian buyer emerges for Reaxa.
February 28, 2011... Mumbai-based S Amit & Co has bought the encapsulated catalyst technology company Reaxa from Blackley Holdings. With the deal, Reaxa's Manchester-based UK staff will be able to focus on the development of the EnCat polymer-encapsulated...

ShangPharma opens cGMP facility.
February 28, 2011... Chinese CRO ShangPharma has started initial production at its multi-purpose pharmaceutical development and cGMP manufacturing facility located in Fengxian in the suburbs of Shanghai. The new plant, which will operate under the name China Gateway...

Codexis in two biocatalysts deals.
February 28, 2011... US-based biocatalysts firm Codexis has forged biocatalysts deals with both DSM Pharmaceutical Products, the custom manufacturing unit of DSM, and Japanese pharmaceutical firm Dainippon Sumitomo Pharma (DSP). Codexis has agreed to provide...

Phoenix in the ashes: Phoenix Chemicals has gone into administration.
February 28, 2011... UK firm Phoenix Chemicals has been put into administration after low sales and production delays led to cash flow difficulties for the firm. RSM Tenon, which started overseeing operations at Phoenix in late Jan 2011, is now scouting for a...

Myriant gets PTT investment in bio-SA.
February 28, 2011... Thai petrochemicals and chemicals maker PTT Chemical has agreed to make a EUR 44.4 M strategic equity investment in Myriant Technologies, a US-based developer and producer of renewable bio-based chemicals, primarily bio-succinic acid (bio-SA)....

BASF, Umicore powered by batteries.
February 28, 2011... BASF and Umicore have both made additional investments to build up their battery materials businesses. BASF, in partnership with the Karlsruhe Institute of Technology (KIT), recently inaugurated a new laboratory in Germany. The company will also...

La Mesta closes ex-Kodak site.
February 28, 2011... La Mesta Chimie Fine, a unit of the AET Group, ceased operations at the La Mesta Bourgogne facility in Chalon-sur-Saone, central France at end-Dec 2010. The former Kodak site has been put into liquidation by the local Chamber of Commerce. The...

ICIG buys Genzyme's Swiss intermediates business.
February 28, 2011... The International Chemical Investors Group (ICIG) has reached an agreement with US biotechnology firm Genzyme Pharmaceuticals to acquire most of the latter's Swiss-based pharmaceutical intermediates business. The deal, which is expected to be...

Bayer's US drugs business suffers.
February 28, 2011... Unexpectedly high special expenses left Bayer with loss of EUR 145 M in 4Q 2010. Special charges rose to EUR 1.72 bn in 2010. As well as writedowns, a total of EUR 703 M was put aside for legal cases. There was a profit of EUR 1.3 bn, compared...

Cultivation of genetically modified plants increasing rapidly.
February 28, 2011... The cultivation of genetically modified crops is increasing rapidly worldwide. The rise was 10% in 2010 to 148 M hectares. The US accounted for 67 M hectares, comprising corn, soya, and cotton. Brazil was next with 25 M hectares a rise of almost...

China's imports of refined copper up again.
February 28, 2011... China's imports of refined copper rose again in Jan 2011, following a slight fall in Dec 2010. Experts say the recovery in Chinese copper demand suggests the trend will continue in the next two months. China's copper producers are cranking up...

Reach renders small-scale production unprofitable.
February 28, 2011... The head of the science, technology and environmental department at the German chemical industries association (VCI), believes that some materials and products have not been registered under the new Reach regulations because companies have...

Mosaic expands MicroEssentials capacity.
February 28, 2011... On 28 Feb 2011, The Mosaic Co announced its investment in a capacity expansion to 2.49 M tons/y for MicroEssentials, one of Mosaic's premium crop nutrition products. This investment will better align future MicroEssentials supply to demand and...

Rhodia completes sale of CERS to World Bank's Spanish Carbon Fund.
February 28, 2011... On 28 Feb 2011, The World Bank and Rhodia SA signed an emission reductions purchase agreement (ERPA) for six M carbon credits generated by Rhodia's nitrous oxide abatement project in Brazil, to be delivered until the end of 2013. The transaction...

SuperGen reports 4Q 2010 and year-end financial results.(Financial report)
February 28, 2011... SuperGen Inc reported financial results for 4Q and year ended Dec 2010. The company reported net income for 4Q 2010 of $6.7 M, or $0.11/share (net income of $2.3 M, or $0.04/share, for 4Q 2009). The company reported net income for 2010 of $16.3...

Range announces 2010 results.(Financial report)
February 28, 2011... Range Resources Corp announced its 4Q and year ended Dec 2010 results. Production increased 14% for 2010 while sequential production growth reached 32 consecutive quarters. Proved reserves increased 42%, with all-in reserve replacement of 931%....

Amyris reports 4Q and 2010 year-end results.(Financial report)
February 28, 2011... Amyris Inc announced financial results for 4Q and year ended Dec 2010. Total revenues for 2010 were $80.3 M ($64.6 M in 2009), with cost of products sold of $70.5 M ($60.4 M in 2009). Research and Development expense increased to $55.2 M ($38.3...

Idenix Pharmaceuticals reports 4Q and year end 2010 financial results.(Financial report)
February 28, 2011... Idenix Pharmaceuticals Inc (Idenix) reported unaudited financial results for 4Q and year ended Dec 2010. For 4Q 2010, Idenix reported total revenues of $2.4 M, ($3 M in 4Q 2009). The company reported a net loss of $16.2 M, or a loss of...

Salix Pharmaceuticals reports 4Q 2010 and 2010 results.(Financial report)
February 28, 2011... Salix Pharmaceuticals Ltd announced financial and operating results for 4Q and year ended Dec 2010. Total product revenue was $118.5 M for 4Q 2010, a 69% increase ($70.2 M for 4Q 2009). Total product revenue for 2010 was $337 M ($232.9 M for...

PDL BioPharma announces 4Q and full year 2010 financial results.(Financial report)
February 28, 2011... PDL BioPharma Inc (PDL) reported financial results for 4Q and full year ended Dec 2010. Total revenues in 2010 were $345 M, ($318.2 M in 2009). Excluding 2009 royalty revenues for sales of Synagis received from MedImmune, royalty revenues for...

Isis reports financial results and highlights for 2010.(Financial report)
February 28, 2011... Isis Pharmaceuticals Inc (Isis) announced its financial results for 4Q and year ended Dec 2010 and reviewed the highlights of 2010. Isis improved upon its 2010 financial guidance with a pro forma net operating loss (NOL) of $36.2 M, which is...

Vivus reports 4Q 2010 and full-year financial results.(Financial report)
February 28, 2011... Vivus Inc reported its highlights and financial results for 4Q and year ended Dec 2010. In 4Q 2010, Vivus reported a net loss from continuing operations of $19.1 M, or $0.23/share, net income from discontinued operations of $12.6 M, or...

Healthzone Ltd reports 1H 2010-2011 results.
February 28, 2011... Healthzone Ltd announced financial results for 1H ended 31 Dec 2010. Consolidated net profit after tax in 1H 2010-2011 increased 25.4% to $2.51 M. Sales revenues in 1H 2010-2011 stood at $58.7 M (+3.4% over $56.8 M in 2009-2010). Healthzone...

Endo Pharmaceuticals raises 2011 financial guidance and reports strong 4Q 2010 financial results.(Financial report)
February 28, 2011... Endo Pharmaceuticals (Endo) reported financial results for 4Q and year ended 31 Dec 2010. Total revenues during 4Q 2010 was $511 M (+31 % over $391 M in 4Q 2009). Net income for 4Q 2010 was $93 M, or $0.77/ diluted share (net income of $148 M,...

Ecopetrol announces results for 4Q and full year 2010.(Financial report)
February 28, 2011... Ecopetrol SA announced its unconsolidated and consolidated financial results for 4Q and audited full year ended Dec 2010 results, prepared and filed in accordance with the Regimen de Contabilidad Publica (Public Accounting Regime - RCP) of the...

Appliance Recycling Centers of America reports 4Q and 2010 operating results.(Financial report)
February 28, 2011... Appliance Recycling Centers of America Inc reported operating results for year and 4Q ended 1 Jan 2011. Total revenues for 4Q 2010 increased 6.9% to $25.3 M ($23.7 M in 4Q 2009). Comparable store revenues from ApplianceSmart Factory Outlets...

JinkoSolar announces 4Q and full year 2010 results.(Financial report)
February 28, 2011... JinkoSolar Holding Co Ltd (JinkoSolar) announced its unaudited financial results for 4Q and full year ended Dec 2010. Total revenues in 4Q 2010 were RMB Yuan 1.8 bn (+156.9% over RMB Yuan 687.8 M in 4Q 2009). Net income in 4Q 2010 was RMB Yuan...

Immunitor presents positive TB treatment data at African Conference.(Conference news)
February 28, 2011... Immune Network Ltd advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis patients in Abuja, Nigeria at the 18th Union TB and Lung Diseases Conference of the African Region, 2-5 Mar 2011. Clinical...

ACT Biotech files special protocol assessment with FDA for Phase III trial of Telatinib for front-line treatment of stomach cancer.
February 28, 2011... ACT Biotech Inc (ACT) has filed a Special Protocol Assessment (SPA) with the US Food and Drug Administration (FDA) related to a randomised Phase III trial of telatinib in combination with chemotherapy for the first-line treatment of patients...

Auris Medical AG starting enrolment in first US clinical trial with AM-101.
February 28, 2011... Auris Medical (Auris) announced that enrolment has started for its Phase II clinical trial with AM-101 for the treatment of acute inner ear tinnitus (TACTT1 study). The study will enrol a total of 24 patients for further evaluation of the...

Harbor BioSciences pre-clinical study of Apoptone in breast cancer published in the International Journal of Breast Cancer.
February 28, 2011... Harbor BioSciences Inc announced publication of the company's study of Apoptone (HE3235) against breast cancer in a pre-clinical rat model. "17a-Ethynyl-5a-androstane-3a, 17B-diol Treatment of MNU-induced Mammary Cancer in Rats," describes the...

NovAliX signs multiyear services agreement for chemistry.
February 28, 2011... NovAlix has entered into a multi-year research services agreement for chemistry with Janssen-Cilag, France, to support its drug discovery efforts. Under the terms, NovAliX scientists will provide distant as well on-site chemistry support,...